n-6 and n-3 Fatty Acids and Atherosclerosis
Authors:
- Alfaidi MAMAlfaidi M
- Chamberlain JCJChamberlain J
- Rothman ARARothman A
- Crossman DCDCrossman D
- Villa‐Uriol MVMVilla‐Uriol M
- Hadoke PHPHadoke P
- Wu JWJWu J
- Schenkel TSTSchenkel T
- Evans PEPEvans P
- Francis SFSFrancis S
- 1 December 2010
- journal article
- editorial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 30 (12) , 2325-2326
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing EffectsCell, 2010
- N-3 vs. saturated fatty acids: Effects on the arterial wallProstaglandins, Leukotrienes and Essential Fatty Acids, 2010
- n-3 Fatty Acids Reduce Arterial LDL-Cholesterol Delivery and Arterial Lipoprotein Lipase Levels and Lipase DistributionArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Omega-6 Fatty Acids and Risk for Cardiovascular DiseaseCirculation, 2009
- The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic DiseasesExperimental Biology and Medicine, 2008
- Lipid mediator informatics-lipidomics: Novel pathways in mapping resolutionThe AAPS Journal, 2006
- n−3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic reviewThe American Journal of Clinical Nutrition, 2006
- Saturated fat–rich diet enhances selective uptake of LDL cholesteryl esters in the arterial wallJournal of Clinical Investigation, 2005
- Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene ExpressionJournal of Biological Chemistry, 2003
- Docosahexaenoic Acid, a Ligand for the Retinoid X Receptor in Mouse BrainScience, 2000